Clearside Biomedical (CLSD) Short Interest Ratio & Short Volume → “Financial tsunami is coming to America” (From Porter & Company) (Ad) Free CLSD Stock Alerts $1.39 +0.04 (+2.96%) (As of 05:27 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Clearside Biomedical Short Interest DataCurrent Short Interest343,300 sharesPrevious Short Interest338,700 sharesChange Vs. Previous Month+1.36%Dollar Volume Sold Short$453,156.00Short Interest Ratio0.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares74,730,000 sharesPercentage of Shares Shorted0.46%Today's Trading Volume168,783 sharesAverage Trading Volume303,663 sharesToday's Volume Vs. Average56% Short Selling Clearside Biomedical ? Sign up to receive the latest short interest report for Clearside Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLSD Short Interest Over TimeCLSD Days to Cover Over TimeCLSD Percentage of Float Shorted Over Time Ad Porter & CompanyThe Worst is Yet to Come…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. Clearside Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024343,300 shares $453,156.00 +1.4%N/A0.9 $1.32 4/30/2024338,700 shares $426,762.00 +27.7%N/A0.9 $1.26 4/15/2024265,300 shares $342,237.00 +18.3%N/A0.7 $1.29 3/31/2024224,300 shares $343,179.00 -34.0%N/A0.6 $1.53 3/15/2024339,900 shares $581,229.00 +23.4%N/A1 $1.71 2/29/2024275,400 shares $385,560.00 +70.1%N/A1 $1.40 Get the Latest News and Ratings for CLSD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024161,900 shares $197,518.00 -12.0%N/A0.9 $1.22 1/31/2024183,900 shares $229,875.00 -12.8%0.4%1 $1.25 1/15/2024210,800 shares $305,660.00 +11.1%0.4%1.1 $1.45 12/31/2023189,700 shares $221,949.00 -43.8%0.4%1 $1.17 12/15/2023337,700 shares $347,831.00 +19.4%0.7%2.1 $1.03 11/30/2023282,900 shares $285,729.00 -3.4%0.6%2.3 $1.01 11/15/2023292,900 shares $281,184.00 +0.8%0.6%2.5 $0.96 10/31/2023290,600 shares $210,568.76 -15.7%0.6%2.3 $0.72 10/15/2023344,500 shares $296,614.50 -1.7%0.7%3.6 $0.86 9/30/2023350,500 shares $304,899.95 -8.5%0.7%3.3 $0.87 9/15/2023382,900 shares $315,892.50 +45.4%0.8%3.4 $0.83 8/31/2023263,400 shares $239,694.00 +20.2%0.5%2.1 $0.91 8/15/2023219,200 shares $217,008.00 -17.5%0.4%1.8 $0.99 7/31/2023265,700 shares $310,869.00 -22.4%0.5%2.2 $1.17 7/15/2023342,400 shares $410,880.00 -17.4%0.7%2.7 $1.20 6/30/2023414,400 shares $464,128.00 -15.0%0.8%3.3 $1.12 6/15/2023487,600 shares $682,640.00 -22.1%1.0%2.9 $1.40 5/31/2023626,100 shares $676,188.00 +10.2%1.2%3.6 $1.08 5/15/2023568,400 shares $608,188.00 +102.8%1.1%3.1 $1.07 4/30/2023280,300 shares $283,103.00 +4.0%0.6%1.5 $1.01 4/15/2023269,600 shares $296,560.00 -19.6%0.5%1.3 $1.10 3/31/2023335,500 shares $348,920.00 -4.5%0.7%1.5 $1.04 3/15/2023351,200 shares $344,176.00 +8.7%0.7%1.5 $0.98 2/28/2023323,100 shares $400,644.00 +0.1%0.7%1.4 $1.24 2/15/2023322,700 shares $432,418.00 +30.5%0.7%1.3 $1.34 1/31/2023247,200 shares $348,552.00 +15.4%0.5%0.8 $1.41 1/15/2023214,300 shares $336,451.00 -48.3%0.4%0.8 $1.57 12/30/2022414,600 shares $464,352.00 +3.8%0.8%1.6 $1.12 12/15/2022399,500 shares $483,395.00 +5.9%0.8%1.8 $1.21 11/30/2022377,100 shares $456,291.00 -32.6%0.8%2 $1.21 11/15/2022559,600 shares $789,036.00 +4.8%1.2%3 $1.41 10/31/2022534,100 shares $608,874.00 +7.7%1.1%4.1 $1.14 10/15/2022495,800 shares $565,212.00 +4.8%1.0%3.9 $1.14 9/30/2022473,100 shares $534,603.00 -9.1%1.0%3.6 $1.13Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 9/15/2022520,300 shares $686,796.00 +11.0%1.1%3.8 $1.32 8/31/2022468,600 shares $641,982.00 +8.3%1.0%3.1 $1.37 8/15/2022432,700 shares $666,358.00 -7.0%0.9%2.8 $1.54 7/31/2022465,100 shares $716,254.00 -20.8%1.0%2.8 $1.54 7/15/2022587,100 shares $1.06 million -10.0%1.2%2.8 $1.81 6/30/2022652,100 shares $958,587.00 -30.9%1.4%2.8 $1.47 6/15/2022944,000 shares $1.26 million -24.5%2.0%3.6 $1.34 5/31/20221,250,000 shares $1.63 million -24.7%2.6%1.4 $1.30 5/15/20221,660,000 shares $2.34 million No Change3.4%1.7 $1.41 4/30/20221,660,000 shares $2.54 million -11.7%3.4%1.7 $1.53 4/15/20221,880,000 shares $3.91 million +36.2%3.9%1.8 $2.08 3/31/20221,380,000 shares $3.16 million -46.7%2.9%1.4 $2.29 3/15/20222,590,000 shares $6.45 million +102.3%5.4%2.5 $2.49 2/28/20221,280,000 shares $2.04 million -3.8%2.7%3 $1.60 2/15/20221,330,000 shares $2.26 million -7.0%2.8%3.1 $1.70 1/31/20221,430,000 shares $2.79 million +28.8%3.0%3.3 $1.95 1/15/20221,110,000 shares $2.48 million -9.0%N/A2.3 $2.23 12/31/20211,220,000 shares $3.36 million -3.2%2.6%2.6 $2.75 12/15/20211,260,000 shares $3.70 million +18.9%2.7%2.4 $2.94 11/30/20211,060,000 shares $3.89 million +1.0%2.2%2.1 $3.67 11/15/20211,050,000 shares $5.07 million -52.3%2.2%2 $4.83 10/29/20212,200,000 shares $12.01 million +81.8%4.6%4 $5.46 10/15/20211,210,000 shares $6.82 million +28.4%2.6%2.1 $5.64 9/30/2021942,500 shares $5.66 million -0.9%2.0%1.6 $6.00 9/15/2021951,200 shares $6.25 million -36.2%2.0%1 $6.57 8/31/20211,490,000 shares $10.27 million -32.6%3.2%0.5 $6.89 8/13/20212,210,000 shares $12.57 million +5.7%4.7%0.7 $5.69 7/30/20212,090,000 shares $10.28 million +11.2%4.7%0.7 $4.92 7/15/20211,880,000 shares $9.95 million +18.2%4.2%0.6 $5.29 6/30/20211,590,000 shares $7.74 million +43.2%3.6%0.5 $4.87 6/15/20211,110,000 shares $4.62 million +37.0%2.5%0.4 $4.16 5/28/2021810,500 shares $2.08 million -6.5%1.9%3.6 $2.57 5/14/2021866,500 shares $2.01 million -9.7%N/A3.2 $2.32 4/30/2021959,100 shares $2.86 million -0.6%N/A2.8 $2.98 4/15/2021965,200 shares $2.58 million +1.9%N/A2.3 $2.67 3/31/2021947,500 shares $2.22 million +44.3%N/A1.6 $2.34 3/15/2021656,600 shares $2.00 million +53.2%N/A0.8 $3.05 2/26/2021428,700 shares $1.39 million -16.9%N/A0.5 $3.25 2/12/2021515,600 shares $1.99 million +29.1%N/A0.6 $3.86 1/29/2021399,400 shares $1.32 million -37.9%N/A0.5 $3.31 1/15/2021643,600 shares $2.70 million -22.7%N/A0.9 $4.20 12/31/2020832,500 shares $1.93 million -16.7%N/A1.4 $2.32 12/15/2020999,700 shares $2.08 million -16.7%2.8%4.1 $2.08 11/30/20201,200,000 shares $2.34 million -12.4%3.3%6 $1.95 11/15/20201,370,000 shares $2.26 million -5.5%3.8%8.8 $1.65 10/30/20201,450,000 shares $2.03 million -0.7%4.2%7.9 $1.40 10/15/20201,460,000 shares $2.13 million -4.6%4.3%6.2 $1.46 9/30/20201,530,000 shares $2.36 million -8.4%4.5%5.7 $1.54 9/15/20201,670,000 shares $2.77 million +3.1%4.9%5.8 $1.66 8/31/20201,620,000 shares $2.79 million -10.5%4.7%4.7 $1.72Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 8/14/20201,810,000 shares $3.24 million +11.0%5.3%4.6 $1.79 7/31/20201,630,000 shares $2.67 million -1.8%4.8%4 $1.64 7/15/20201,660,000 shares $2.79 million +5.7%5.0%4.2 $1.68 6/30/20201,570,000 shares $2.95 million -0.6%4.7%3.8 $1.88 6/15/20201,580,000 shares $3.24 million +4.0%4.8%3.8 $2.05 5/29/20201,520,000 shares $2.83 million +2.0%4.6%3.2 $1.86 5/15/20201,490,000 shares $2.95 million -0.7%4.5%3 $1.98 4/30/20201,500,000 shares $2.97 million -10.2%4.5%2.9 $1.98 4/15/20201,670,000 shares $4.02 million -10.2%5.0%2.4 $2.41 3/31/20201,860,000 shares $4.09 million -28.7%5.6%2 $2.20 3/13/20202,609,700 shares $4.54 million -3.7%10.7%3.5 $1.74 2/28/20202,710,000 shares $3.71 million +1.5%11.1%2.1 $1.37 2/14/20202,670,000 shares $6.68 million +11.3%8.1%2.1 $2.50 1/31/20202,400,000 shares $6.02 million +62.2%7.5%1.9 $2.51 1/15/20201,480,000 shares $4.14 million -2.0%4.6%1.2 $2.80 12/31/20191,510,000 shares $4.18 million +112.5%4.7%1.4 $2.77 CLSD Short Interest - Frequently Asked Questions What is Clearside Biomedical's current short interest? Short interest is the volume of Clearside Biomedical shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 343,300 shares of CLSD short. Learn More on Clearside Biomedical's current short interest. What is a good short interest ratio for Clearside Biomedical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLSD shares currently have a short interest ratio of 1.0. Learn More on Clearside Biomedical's short interest ratio. Which institutional investors are shorting Clearside Biomedical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clearside Biomedical: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Clearside Biomedical's short interest increasing or decreasing? Clearside Biomedical saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 343,300 shares, an increase of 1.4% from the previous total of 338,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Clearside Biomedical's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Clearside Biomedical: Eyenovia, Inc. (10.27%), Neurogene Inc. (8.58%), Theravance Biopharma, Inc. (13.37%), Terns Pharmaceuticals, Inc. (5.19%), Acelyrin, Inc. (11.18%), Esperion Therapeutics, Inc. (16.09%), AC Immune SA (2.79%), Adlai Nortye Ltd. (0.03%), Ventyx Biosciences, Inc. (16.38%), Verrica Pharmaceuticals Inc. (14.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Clearside Biomedical stock? Short selling CLSD is an investing strategy that aims to generate trading profit from Clearside Biomedical as its price is falling. CLSD shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clearside Biomedical? A short squeeze for Clearside Biomedical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLSD, which in turn drives the price of the stock up even further. How often is Clearside Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLSD, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Eyenovia Short Squeeze Neurogene Short Squeeze Theravance Biopharma Short Squeeze Terns Pharmaceuticals Short Squeeze Acelyrin Short Squeeze Esperion Therapeutics Short Squeeze AC Immune Short Squeeze Adlai Nortye Short Squeeze Ventyx Biosciences Short Squeeze Verrica Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLSD) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward PressDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaMAJOR BUY SIGNAL: Move Fast, Washington/Pelosi/Mill…Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.